Keith M. Heaton

752 total citations
13 papers, 480 citations indexed

About

Keith M. Heaton is a scholar working on Immunology, Oncology and Cancer Research. According to data from OpenAlex, Keith M. Heaton has authored 13 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Keith M. Heaton's work include Immunotherapy and Immune Responses (5 papers), Breast Cancer Treatment Studies (3 papers) and Cancer Genomics and Diagnostics (3 papers). Keith M. Heaton is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Breast Cancer Treatment Studies (3 papers) and Cancer Genomics and Diagnostics (3 papers). Keith M. Heaton collaborates with scholars based in United States, Australia and Switzerland. Keith M. Heaton's co-authors include Elizabeth A. Grimm, Merrick I. Ross, G Ju, Adel K. El‐Naggar, Lisa G. Ensign, Douglas S. Reintgen, Paul F. Mansfield, Jeffrey E. Lee, Jonathan Sussman and Jeffrey E. Gershenwald and has published in prestigious journals such as Cancer, Annals of Surgery and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Keith M. Heaton

13 papers receiving 459 citations

Peers

Keith M. Heaton

ONCOL

EPIDE

IMMUN

N. J. Robert United States

D Reintgen United States

Carolyn Nessim Canada

Aaron S. Weinberg United States

Giammarco Surico Italy

Leslie A. Cagle United States

Séamus S. Napier United Kingdom

Meghan R. Forster United States

Markwin G. Statius Muller Netherlands

Yasunori Yoshimoto Japan

N. J. Robert United States

Keith M. Heaton

264 ×0.9

ONCOL

193 ×1.4

EPIDE

83 ×0.7

IMMUN

62 ×0.8

58 ×0.8

Citations per year, relative to Keith M. Heaton Keith M. Heaton (= 1×) peers N. J. Robert

Countries citing papers authored by Keith M. Heaton

Since Specialization

Citations

This map shows the geographic impact of Keith M. Heaton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith M. Heaton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith M. Heaton more than expected).

Fields of papers citing papers by Keith M. Heaton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith M. Heaton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith M. Heaton. The network helps show where Keith M. Heaton may publish in the future.

Co-authorship network of co-authors of Keith M. Heaton

This figure shows the co-authorship network connecting the top 25 collaborators of Keith M. Heaton. A scholar is included among the top collaborators of Keith M. Heaton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith M. Heaton. Keith M. Heaton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Swenson, Karen K., Amit Mahipal, Mary Jo Nissen, et al.. (2005). Axillary disease recurrence after sentinel lymph node dissection for breast carcinoma. Cancer. 104(9). 1834–1839. 34 indexed citations

Freedman, Laura, Thomas A. Buchholz, Howard D. Thames, et al.. (2000). Local-regional control in breast cancer patients with a possible genetic predisposition. International Journal of Radiation Oncology*Biology*Physics. 48(4). 951–957. 5 indexed citations

Mumtaz, Hamid, Victor Williams, Martin Hauer‐Jensen, et al.. (2000). Central venous catheter placement in patients with disorders of hemostasis. The American Journal of Surgery. 180(6). 503–506. 71 indexed citations

Heaton, Keith M., George E. Peoples, S. Eva Singletary, et al.. (1999). Feasibility of Breast Conservation Therapy in Metachronous or Synchronous Bilateral Breast Cancer. Annals of Surgical Oncology. 6(1). 102–108. 24 indexed citations

Heaton, Keith M., Jonathan Sussman, Jeffrey E. Gershenwald, et al.. (1998). Surgical margins and prognostic factors in patients with thick (>4 mm) primary melanoma. Annals of Surgical Oncology. 5(4). 322–328. 125 indexed citations

Heaton, Keith M. & Elizabeth A. Grimm. (1995). Differential inhibition of lymphokine-activated killing, proliferation, and cytokine secretion by humanized antibodies against the low- and intermediate-affinity interleukin-2 receptors. Human Immunology. 42(3). 274–280. 11 indexed citations

Heaton, Keith M., et al.. (1994). Surgical Management and Prognostic Factors in Patients with Subungual Melanoma. Annals of Surgery. 219(2). 197–204. 88 indexed citations

Heaton, Keith M., G Ju, & Elizabeth A. Grimm. (1994). Induction of lymphokine-activated killing with reduced secretion of interleukin-1β, tumor necrosis factor-α, and interferon-γ by interleukin-2 analogs. Annals of Surgical Oncology. 1(3). 198–203. 12 indexed citations

Heaton, Keith M., et al.. (1993). Characterization of Lymphokine-Activated Killing by Human Peripheral Blood Mononuclear Cells Stimulated with Interleukin 2 (IL-2) Analogs Specific for the Intermediate Affinity IL-2 Receptor. Cellular Immunology. 147(1). 167–179. 15 indexed citations

10.

Heaton, Keith M., et al.. (1993). Prognostic implications of DNA index in patients with stage III cutaneous melanoma. The American Journal of Surgery. 166(6). 648–653. 7 indexed citations

11.

Heaton, Keith M. & Elizabeth A. Grimm. (1993). Cytokine combinations in immunotherapy for solid tumors: a review. Cancer Immunology Immunotherapy. 37(4). 213–219. 26 indexed citations

12.

Heaton, Keith M., G Ju, & Elizabeth A. Grimm. (1993). Human interleukin 2 analogues that preferentially bind the intermediate-affinity interleukin 2 receptor lead to reduced secondary cytokine secretion: implications for the use of these interleukin 2 analogues in cancer immunotherapy.. PubMed. 53(11). 2597–602. 52 indexed citations

13.

Heaton, Keith M., et al.. (1989). Comparative Analysis of a Human Pancreatic Undifferentiated Cell Line (MIA PaCa-2) to Acinar and Ductal Cells. Pancreas. 4(5). 529–537. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact